Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 2, 2010, Pages 142-149

  Matoso, Andres ^a   Singh, Kamaljeet ^a   Jacob, Rafik ^a   Greaves, Wesley O ^a   Tavares, Rosemarie ^a   Noble, Lelia ^a   Resnick, Murray B ^a   Delellis, Ronald A ^a   Wang, Li J ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

8G7G3 1 clone; SPT24 clone; Thyroid transcription factor 1; Tissue microarrays

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 8G7G1; MONOCLONAL ANTIBODY 8G7G3; MONOCLONAL ANTIBODY SPT24; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; BREAST CARCINOMA; BREAST TUMOR; BRONCHUS CARCINOID; COLON CARCINOMA; COLON TUMOR; COMPARATIVE STUDY; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HEAD AND NECK TUMOR; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; MAJOR CLINICAL STUDY; METASTASIS; MOLECULAR CLONING; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE TUMOR; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; SALIVARY GLAND TUMOR; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOMA; STOMACH TUMOR; TISSUE MICROARRAY; UROGENITAL TRACT CANCER;

ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; ORGAN SPECIFICITY; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 77649174473     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181bdf4e7     Document Type: Article

References (29)

1. Cassel TN, Suske G, Nord M. C/EBP alpha and TTF-1 synergistically transactivate the Clara cell secretory protein gene. Ann N Y Acad Sci. 2000;923:300-302.
2. Civitareale D, Castelli MP, Falasca P, et al.. Thyroid transcription factor 1 activates the promoter of the thyrotropin receptor gene. Mol Endocrinol. 1993;7:1589-1595.
3. Francis-Lang H, Price M, Polycarpou-Schwarz M, et al.. Cell-typespecific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression. Mol Cell Biol. 1992;12:576-588.
4. Bruno MD, Korfhagen TR, Liu C, et al.. GATA-6 activates transcription of surfactant protein A. J Biol Chem. 2000;275: 1043-1049.
5. Ikeda K, Clark JC, Shaw-White JR, et al.. Gene structure and expression of human thyroid transcription factor-1 in respiratory epithelial cells. J Biol Chem. 1995;270:8108-8114.
6. Jerome Marson V, Mazieres J, Groussard O, et al.. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade. Histopathology. 2004;45:125-134.
7. Kargi A, Gurel D, Tuna B. The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas. Appl Immunohistochem Mol Morphol. 2007;15:415-420.
8. Moldvay J, Jackel M, Bogos K, et al.. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res. 2004;10:85-88.
9. Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology. 2000;36:8-16.
10. Ng WK, Chow JC, Ng PK. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens. Cancer. 2002;96:43-48.
11. Penman D, Downie I, Roberts F. Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution. J Clin Pathol. 2006;59:663-664.
12. Graham AD, Williams AR, Salter DM. TTF-1 expression in primary ovarian epithelial neoplasia. Histopathology. 2006;48:764-765.
13. Siami K, McCluggage WG, Ordonez NG, et al.. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am J Surg Pathol. 2007;31:1759-1763.
14. Zhang PJ, Gao HG, Pasha TL, et al.. TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems. Int J Gynecol Pathol. 2009;28:10-18.
15. Holzinger A, Dingle S, Bejarano PA, et al.. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Hybridoma. 1996;15:49-53.
16. Lazzaro D, Price M, de Felice M, et al.. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development. 1991; 113:1093-1104.
17. Agoff SN, Lamps LW, Philip AT, et al.. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol. 2000;13:238-242.
18. Alkushi A, Irving J, Hsu F, et al.. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch. 2003;442:271-277.
19. Zamecnik J, Chanova M, Kodet R. Expression of thyroid transcription factor 1 in primary brain tumours. J Clin Pathol. 2004;57:1111-1113.
20. Galloway M, Sim R. TTF-1 staining in glioblastoma multiforme. Virchows Arch. 2007;451:109-111.
21. Agaimy A, Wunsch PH. Unexpected and potentially misleading TTF-1 expression: a word of caution. Virchows Arch. 2006; 449:603-605.
22. Kubba LA, McCluggage WG, Liu J, et al.. Thyroid transcription factor-1 expression in ovarian epithelial neoplasms. Mod Pathol. 2008;21:485-490.
23. Wong NA, Kamel H, Sheffield EA, et al.. Positive immunostaining for thyroid transcription factor-1 in colorectal adenocarcinoma using the 8G7G3/1 monoclonal antibody. J Clin Pathol. 2008;61:1070-1071.
24. Rau T, Dimmler A, Hafner M, et al.. Aberrant expression of TTF-1 and forkhead factor HFH-4 in atrophic gastritis and ciliated metaplasia suggests gastric broncho-pulmonary transdetermination. J Pathol. 2005;206:383-387.
25. Lim TK, Teo C, Giron DM, et al.. Thyroid transcription factor-1 may be expressed in ductal adenocarcinoma of the prostate: a potential pitfall. J Clin Pathol. 2007;60:941-943.
26. Plaza JA, Suster D, Perez-Montiel D. Expression of immunohistochemical markers in primary and metastatic malignant melanoma: a comparative study in 70 patients using a tissue microarray technique. Appl Immunohistochem Mol Morphol. 2007;15:421-425.
27. Bisceglia M, Ragazzi M, Galliani CA, et al.. TTF-1 expression in nephroblastoma. Am J Surg Pathol. 2009;33:454-461.
28. Oliveira AM, Tazelaar HD, Myers JL, et al.. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol. 2001;25: 815-819.
29. Pelosi G, Fraggetta F, Pasini F, et al.. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol. 2001;25:363-372.